Cognitive function and quality of life after surgery for early breast cancer in North Jutland, Denmark

被引:44
作者
Debess, Jeanne [2 ]
Riis, Jens Ostergaard [3 ]
Pedersen, Lars [4 ]
Ewertz, Marianne [1 ]
机构
[1] Univ So Denmark, Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark
[2] Aarhus Univ, Aalborg Hosp, Dept Oncol, Aalborg, Denmark
[3] Aarhus Univ, Aalborg Hosp, Dept Neurol, Aalborg, Denmark
[4] Aarhus Univ, Dept Clin Epidemiol, Aalborg, Denmark
关键词
ADJUVANT TREATMENT; DOSE CHEMOTHERAPY; WOMEN; DYSFUNCTION; IMPAIRMENT; THERAPY; COHORT; ADULT; RISK;
D O I
10.1080/02841860802600755
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. The aim of this study was to assess cognitive function, quality of life, and psychological distress after surgery for early breast cancer but before initiation of adjuvant treatment. Material and methods. We performed a population-based study in the county of North Jutland, Denmark, including 124 women aged less than 60 years who had surgery for early breast cancer from 2004 - 2006. They were compared with an aged-matched group of 224 women without previous cancer selected randomly from the same population. The cognitive function of patients and controls was tested using a revised battery from the ISPOCD study. Data were collected on quality of life (EORTC QLQ-C30) and psychological distress (POMS). Result. The neuropsychological tests did not reveal significant differences between patients and controls. Compared to the control group, breast cancer patients had a significantly 3 - 4 fold increased risk of experiencing cognitive impairment. Quality of life and psychological distress were also significantly poorer among patients. Conclusion. This study demonstrated that women diagnosed with breast cancer experience a significant deterioration of their perceived cognitive functioning, quality of life and of psychological well being.
引用
收藏
页码:532 / 540
页数:9
相关论文
共 26 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
AHLES TA, 2007, BREAST CANC RES TREA
[3]  
[Anonymous], 1995, EORTC QLQ C30 SCORIN
[4]   Cognitive impairment associated with adjuvant therapy in breast cancer [J].
Bender, Catherine M. ;
Sereika, Susan M. ;
Berga, Sarah L. ;
Vogel, Victor G. ;
Brufsky, Adam M. ;
Paraskar, Karen K. ;
Ryan, Christopher M. .
PSYCHO-ONCOLOGY, 2006, 15 (05) :422-430
[5]  
Bender CM, 2005, CANCER NURS, V28, P219
[6]   Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group study 9401 [J].
Brandberg, Y ;
Michelson, H ;
Nilsson, B ;
Bolund, C ;
Erikstein, B ;
Hietanen, P ;
Kaasa, S ;
Nilsson, J ;
Wiklund, T ;
Wilking, N ;
Bergh, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3659-3664
[7]   Depression and anxiety in women with early breast cancer: five year observational cohort study [J].
Burgess, C ;
Cornelius, V ;
Love, S ;
Graham, J ;
Richards, M ;
Ramirez, A .
BRITISH MEDICAL JOURNAL, 2005, 330 (7493) :702-705
[8]   Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer [J].
Cimprich, B ;
Ronis, DL ;
Trask, C .
PSYCHO-ONCOLOGY, 2005, 14 (01) :70-78
[9]   Socioeconomic status and breast cancer in Denmark [J].
Dano, H ;
Andersen, O ;
Ewertz, M ;
Petersen, JH ;
Lynge, E .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2003, 32 (02) :218-224
[10]   Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study [J].
Ewertz, M ;
Mellemkjaer, L ;
Poulsen, AH ;
Friis, S ;
Sorensen, HT ;
Pedersen, L ;
McLaughlin, JK ;
Olsen, JH .
BRITISH JOURNAL OF CANCER, 2005, 92 (07) :1293-1297